LGND Ligand Pharmaceuticals Incorporated
LGND Ligand Pharmaceuticals Incorporated
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $197.87 · VWAP $245.00 · +20.6% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CFO, Director + 1 other sold $12.8M, Aug 4–14
Coverage
1 watchlist
LGND Price Structure
Loading timeframes…
Peers
Every watchlist LGND belongs to, members best 30-day change first — LGND highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How LGND's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about LGND from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 4 days ago · Oct 13
- Ligand Pharmaceuticals (LGND) Q2 2026 Earnings Call Transcript & Audio
- Ligand Stock Price Today | NASDAQ: LGND Live - Investing.com
- Ligand Pharmaceuticals (LGND) Stock Price & Overview
- Ligand Pharmaceuticals Incorporated - Ligand Reports Second Quarter 2026 Financial Results
- Ligand Pharmaceuticals Incorporated TradeGate Share News (LGND)
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
LGND research tape
54 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.